kmatija/E+ via Getty Images
- Emerald Health Therapeutics (OTCQX:EMHTF) and HYTN Cannabis have signed a definitive agreement to co-launch, sell and distribute HYTN's proprietary new sparkling cannabis beverages across Canada.
- The partnership will leverage Emerald's established cannabis sales license, sales team and infrastructure, and provincial cannabis wholesale and retail distribution relationships to sell HYTN's products.
- Emerald will receive a double-digit percentage fee on total gross sales revenue (less excise tax) of HYTN products in Canada.
- HYTN intends to launch its cannabis beverages this quarter, with Emerald having already secured an initial purchase order for HYTN cannabis beverages in British Columbia.